Chu, Che-Sheng, Li, Cheng-Ta, Brunoni, Andre R., Yang, Fu-Chi, Tseng, Ping-Tao, Tu, Yu-Kang, Stubbs, Brendon, Carvalho, André F., Thompson, Trevor ORCID: 0000-0001-9880-782X, Rajji, Tarek K., Yeh, Ta-Chuan, Tsai, Chia-Kuang, Chen, Tien-Yu, Li, Dian-Jeng, Hsu, Chih-Wei, Wu, Yi-Cheng, Yu, Chia-Ling and Liang, Chih-Sung (2020) Cognitive effects and tolerability of non-invasive brain stimulation on Alzheimer’s disease and mild cognitive impairment: a component network meta-analysis. Journal of Neurology, Neurosurgery, and Psychiatry, 92 (2). pp. 195-203. ISSN 0022-3050 (Print), 1468-330X (Online) (doi:https://doi.org/10.1136/jnnp-2020-323870)

Preview

PDF (Publisher's PDF - Open Access) 29861 THOMPSON_Cognitive_Effects_and_Acceptability_of_Non-Invasive_Brain_Stimulation_(OA)_2020.pdf - Published Version Available under License Creative Commons Attribution Non-commercial. Download (2MB) | Preview

Abstract

Objectives:
To compare cognitive effects and acceptability of repetitive transcranial magnetic stimulation (rTMS) and transcranial direct current stimulation (tDCS) in patients with Alzheimer’s disease (AD) or mild cognitive impairment (MCI), and to determine whether cognitive training (CT) during rTMS or tDCS provides additional benefits.

Methods:
Electronic search of PubMed, Medline, Embase, the Cochrane Library and PsycINFO up to 5 March 2020. We enrolled double-blind, randomised controlled trials (RCTs). The primary outcomes were acceptability and pre–post treatment changes in general cognition measured by Mini-Mental State Examination, and the secondary outcomes were memory function, verbal fluency, working memory and executive function. Durability of cognitive benefits (1, 2 and ≥3 months) after brain stimulation was examined.

Results:
We included 27 RCTs (n=1070), and the treatment components included high-frequency rTMS (HFrTMS) and low-frequency rTMS, anodal tDCS (atDCS) and cathodal tDCS (ctDCS), CT, sham CT and sham brain stimulation. Risk of bias of evidence in each domain was low (range: 0%–11.1%). HFrTMS (1.08, 9, 0.35–1.80) and atDCS (0.56, 0.03–1.09) had short-term positive effects on general cognition. CT might be associated with negative effects on general cognition (−0.79, –2.06 to 0.48) during rTMS or tDCS. At 1-month follow-up, HFrTMS (1.65, 0.77–2.54) and ctDCS (2.57, 0.20–4.95) exhibited larger therapeutic responses. Separate analysis of populations with pure AD and MCI revealed positive effects only in individuals with AD. rTMS and tDCS were well tolerated.

Conclusions:
HFrTMS is more effective than atDCS for improving global cognition, and patients with AD may have better responses to rTMS and tDCS than MCI.

Item Type:	Article
Additional Information:	© Author(s) (or their employer(s)) 2020. Open Access. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
Uncontrolled Keywords:	non-invasive brain stimulation; repetitive transcranial magnetic stimulation; transcranial direct current stimulation; cognitive function; Alzheimer’s disease; mild cognitive impairment
Subjects:	B Philosophy. Psychology. Religion > BF Psychology
Faculty / School / Research Centre / Research Group:	Faculty of Education, Health & Human Sciences Faculty of Education, Health & Human Sciences > School of Human Sciences (HUM)
Last Modified:	27 Jul 2021 15:38
URI:	http://gala.gre.ac.uk/id/eprint/29861

Actions (login required)

View Item

Downloads